Improving newborn health by testing for malaria early in pregnancy
Improving Neonatal health Through Rapid malaria testing in Early Pregnancy with high-sensitivity Diagnostics (INTREPiD)
This study is looking to help pregnant women in sub-Saharan Africa by testing for malaria early in their pregnancy to see if it can lead to healthier babies and better birth weights compared to the usual care.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-11061234 on NIH RePORTER |
What this research studies
This research aims to reduce neonatal mortality in sub-Saharan Africa by implementing early malaria screening for pregnant women in their first trimester using high-sensitivity rapid diagnostic tests. The study will compare outcomes between women who receive standard care and those who are screened for malaria early in their pregnancy. By identifying and treating malaria infections sooner, the research seeks to improve birth weights and overall health outcomes for newborns. The approach is based on updated guidelines and the availability of effective treatments for malaria during early pregnancy.
Who could benefit from this research
Good fit: Ideal candidates for this research are pregnant women in their first trimester living in sub-Saharan Africa.
Not a fit: Patients who are not pregnant or those in regions outside of sub-Saharan Africa may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly lower the rates of low birth weight and neonatal mortality associated with malaria infections during pregnancy.
How similar studies have performed: Previous research has shown that early malaria screening and treatment can improve pregnancy outcomes, suggesting a strong potential for success with this approach.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Taylor, Steve Myer — Duke University
- Study coordinator: Taylor, Steve Myer
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.